top of page

Learn About How CureScience™ is Impacting the World of Healthcare

XCures partners with CureScience to make leading translational research available to advanced cancer patients

Provided By: CureScience Institute

May 18, 2021

CureScience™ CEO Wants to ‘Cocreate, Not Compete’ to Advance Health Care

Provided By: Del Mar Times

Oct 27, 2020

Curtana Pharmaceuticals’ CT-179 Receives Rare Pediatric Disease Designation from the U.S. FDA for the Treatment of Medulloblastoma

Provided By: Curtana Pharmaceuticals

Oct 06, 2020

Gary Shields Joins CureScience™ Institute Advisory Board to Accelerate Innovation

Provided By: CureScience Institute

Aug 25, 2020

First COVID-19 Patient Treated Under Emergency Use IND At Providence Saint John's Health Center Using Stemedica Ischemia-Tolerant Allogeneic Mesenchymal Bone Marrow Cells

Provided By: Stemedica Cell Technologies, Inc.

Apr 20, 2020

Dr. Boris Reznik joins CureScience's Advisory Board Member

Provided By: CureScience Institute

Feb 23, 2021

Mesenchymal Stem Cells as Living Anti-inflammatory Therapy for COVID-19 Related Acute Respiratory Distress Syndrome

Provided By: CureScience Institute

Oct 26, 2020

CureScience™ Institute Announces Dr. Franco Marincola as New Advisory Board Member

Provided By: CureScience Institute

Sept 03, 2020

CureScience™ Institute Expands Vision and Advisory Board to Accelerate Innovation

Provided By: CureScience Institute

Jul 16, 2020

bottom of page